Dechra – veterinary pharmaceutical products #pharmaceuticals #news

Posted On Oct 30 2016 by

#pharmaceutical products # Dechra is an international specialist veterinary pharmaceuticals products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Veterinarians and pet owners provide their views on the treatment of Cushing’s disease SPECIFIC TM Pet food that feeds something very important Share price: 1300.00p Time: 2:12pm Date: 4 Sep 2016 Countries Select a country web site. Dechra offers a broad range of market-leading pharmaceuticals. Dechra’s product range treats patients in a wide variety of therapy areas. Find out about the areas of business that make up the Dechra …


Pharmaceutical Industry Overview of Global companies #mayne #pharma

Posted On Oct 30 2016 by

#pharmaceutical industry overview # Industry Overview Indian Pharmaceutical Industry Indian pharmaceutical market is among the top five emerging pharmaceutical markets in the world According to McKinsey Company report (“India Pharma 2015”), the following trends influence the growth of the Indian pharmaceuticals market: Doubling of disposable incomes and the number of middle-class households Expansion of medical infrastructure Greater penetration of health insurance Rising prevalence of chronic diseases Adoption of product patents Aggressive market penetration driven by the relatively smaller companies The revenue CAGR from 2009-2012 has been 12.4%, and is expected to increase to 14-17% between 2012-2016 This growth is expected …


Pharmaceutical and Prescription Medicine Products #pharmaceutical #industry #overview #2013

Posted On Oct 30 2016 by

#pharmaceutical products # The Janssen Pharmaceutical Companies of Johnson Johnson address some of the most devastating and complex diseases of our age through research and development of prescription medicines including biologics and other novel treatments. Spending more than $6 billion in R D in 2014, Janssen is investing in a transformative future, changing the way diseases are interpreted, managed and prevented. Our pharmaceutical and biologic medicines are focused in five areas of healthcare. Click on the therapeutic area below to find medicines. Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with key stakeholders …


Services for Pharmaceutical products, Analytical Methods, Ecotoxicological studies, Environmental fate and behaviour studies #pharmaceutical #industry #news

Posted On Oct 30 2016 by

#pharmaceutical products # PHARMACEUTICAL PRODUCTS A Medicinal product is defined as any substance or combination of substances presented for treating or preventing disease in human beings. Any substance or combination of substances which may be administered to human beings with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in human beings is likewise considered a medicinal product. Medicinal products are regulated by the Directive 2001/83/EC. According to the implementation of this Directive the evaluation of the potential environmental risks posed by medicinal products should be submitted, their environmental impact should be assessed and, …


Par Pharmaceutical #endo #pharma

Posted On Oct 30 2016 by

#pharmaceutical products # The development and growth of the generic pharmaceutical industry over the past 30 years has come as a response to rising healthcare costs. Generic pharmaceuticals, which are carefully manufactured formulations of the original, patented “brand name” products, help to make American healthcare more affordable. For more information on generic drugs, visit the FDA’s Office of Generic Drugs webpage. Answer. Yes, Generic pharmaceutical manufacturers must provide to the FDA that their version of the drug: contains the same active ingredient; is identical in strength, dosage form, and route of administration; has the same indications, dosing, and labeling; and …


Healthcare and Pharmaceutical Logistics #jobs #in #pharmacy

Posted On Oct 30 2016 by

#pharma logistics # Healthcare and Pharmaceutical Logistics Dedicated Solutions for the Global Healthcare Industry, Delivered with Full Compliance Yusen Logistics has invested heavily over the past 20 years in developing specialist new services and resources in the global pharma, biotech and healthcare supply chain. That’s why we can bring you so much extra value, allowing your supply chain to deliver strategic competitive advantage rather than simply being an unavoidable operational cost. Solutions range from the delivery of raw materials into the manufacturing process to delivery of finished drugs and equipment to in-market distributors, hospitals, pharmacies and surgeries. Whether modelling and …


Pharmaceutical Logistics #avema #pharma #solutions

Posted On Oct 30 2016 by

#pharma logistics # Pharmaceutical Logistics GENCO provides logistics support to approximately 80 healthcare product manufacturers. as well as their wholesale, retail and hospital customers. We have the systems capabilities and operational expertise in warehousing and distribution to meet all the demands of this heavily regulated industry. GENCO has extensive experience in regulated operations. Our medical-grade facilities are scalable and include the following: Regulatory expertise: FDA, DEA, DOT, EPA Documentation/SOPs FDA registrations/licensing ISO certification (9001, 13485) VAWD accreditation Pedigree/cGDP/C-TPAT CSOS GENCO Value Drivers for Pharmaceutical Logistics Compliant Facilities – PDMA- and cGMP-compliant healthcare and pharmaceutical warehouse facilities exceed the standards of …


EFPIA – The Pharmaceutical Industry in figures – Edition 2013 #cardiome #pharma #corp

Posted On Oct 30 2016 by

#pharmaceutical industry overview 2013 # The Pharmaceutical Industry in figures – Edition 2013 Main Trends The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and ensuring future competitiveness in an advancing global economy. In 2012 it invested an estimated € 30,000 million in R /* 728×90, создано 05.02.11 */ google_ad_slot = “6127977750”; google_ad_width = 670; google_ad_height = 90; //–>


Pharmaceutical information #pharma #gossip

Posted On Oct 30 2016 by

#pharmaceutical information # Erelzi Erelzi (etanercept-szzs) is a tumor necrosis factor (TNF) blocker biosimilar to Enbrel indicated for the treatment of rheumatoid arthritis. Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent, narcotic analgesic formulation. Sustol Sustol (granisetron) is a long-acting 5-HT3 antagonist indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV). Drugs in Development (Not yet approved) Ingrezza Ingrezza (valbenazine) is a novel, highly-selective VMAT2 inhibitor in development for the treatment of tardive dyskinesia. brigatinib Brigatinib is an investigational anaplastic lymphoma kinase (ALK) inhibitor in development for the treatment of patients with anaplastic. Radicava …


Pharmaceutical company may not expand in Durham after HB2 passage #biotechnology #industry #news

Posted On Oct 30 2016 by

#pharmaceutical companies in charlotte nc # Pharmaceutical company may not expand in Durham after HB2 passage DURHAM, N.C. A pharmaceutical company is reconsidering plans to expand in the Triangle after the NC legislature passed a law it considers discriminatory against transgender persons. Just two weeks ago, Braeburn Pharmaceuticals, Inc. announced, with Gov. Pat McCrory speaking in support, that the company would establish a manufacturing and research facility in Durham Co. Less than a week later, during a one-day special session, the N.C. General Assembly passed HB2 which eliminated a Charlotte ordinance that allowed transgender people to use the bathroom of …